Hepatocellular Carcinoma Clinical Trials in Seoul
26 recruitingSeoul, South Korea
Showing 1–20 of 26 trials
Recruiting
Phase 1
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Metastatic Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Alnylam Pharmaceuticals158 enrolled23 locationsNCT06600321
Recruiting
Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Biliary Tract CancerHepatocellular Carcinoma
AstraZeneca294 enrolled60 locationsNCT05775159
Recruiting
Streamlining Radioembolization for Small HCC
Hepatocellular Carcinoma (HCC)
Seoul National University Hospital146 enrolled4 locationsNCT06979219
Recruiting
Same-day Radioembolization for Large HCC
Hepatocellular Carcinoma (HCC)
Seoul National University Hospital138 enrolled4 locationsNCT06944483
Recruiting
Phase 1Phase 2
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
AstraZeneca304 enrolled20 locationsNCT06795022
Recruiting
Imjudo & Imfinzi PMS
Hepatocellular Carcinoma
AstraZeneca246 enrolled6 locationsNCT06544629
Recruiting
Not Applicable
A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)
Hepatocellular CarcinomaCarcinoma
Yonsei University48 enrolled1 locationNCT07252323
Recruiting
Phase 2
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
Hepatocellular CarcinomaCarcinomaLiver Neoplasms+1 more
Yonsei University52 enrolled1 locationNCT07246668
Recruiting
Phase 2
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Locally Advanced Hepatocellular Carcinoma
National Cancer Centre, Singapore100 enrolled14 locationsNCT05377034
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Rznomics, Inc.45 enrolled9 locationsNCT06695026
Recruiting
Phase 2
Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria
Hepatocellular Carcinoma (HCC)Radioembolization
Seoul National University Hospital100 enrolled4 locationsNCT06773845
Recruiting
Phase 1Phase 2
Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma (HCC)
Yoon Jun Kim24 enrolled1 locationNCT06911255
Recruiting
Ate-Bev Early Response Prediction Model in Advanced HCC
Hepatocellular CarcinomaAtezolizumab-bevacizumabResponse Evaluation
Seoul National University Hospital170 enrolled1 locationNCT05763277
Recruiting
Phase 2
Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis
Hepatocellular Carcinoma
Seoul National University Hospital30 enrolled4 locationsNCT06166576
Recruiting
Phase 2
Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
Liver CancerHepatocellular CarcinomaHepatocellular Cancer+2 more
Asan Medical Center138 enrolled1 locationNCT05992220
Recruiting
Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation
Hepatocellular CarcinomaLiver Cirrhosis
Yonsei University350 enrolled1 locationNCT06767579
Recruiting
Phase 2
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma
Liver CancerHepatocellular Carcinoma
Seoul National University Hospital128 enrolled1 locationNCT06114082
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+3 more
GI Innovation, Inc.358 enrolled11 locationsNCT05824975
Recruiting
Phase 1
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma
Liver CancerHepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Etnova Therapeutics Corp.50 enrolled2 locationsNCT06326502
Recruiting
Phase 1
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
Advanced Hepatocellular Carcinoma
Eutilex12 enrolled4 locationsNCT05783570